METASTATIC BASAL CELL CARCINOMA

Clinical trials for METASTATIC BASAL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC BASAL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC BASAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for kidney transplant patients with cancer: drug combo aims to fight tumors without losing the donated kidney

Disease control Ongoing

This early-stage study tests whether a mix of three drugs—tacrolimus, nivolumab, and ipilimumab—can shrink or control certain skin cancers in people who have had a kidney transplant. The main goal is to see if the cancer responds without causing the body to reject the transplante…

Matched conditions: METASTATIC BASAL CELL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

METASTATIC BASAL CELL CARCINOMA

Get alerted when new METASTATIC BASAL CELL CARCINOMA trials appear

New hope for kidney transplant patients with cancer: drug combo aims to fight tumors without losing the donated kidney